Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03740113 · ClinicalTrials.gov registry record · NA
Kids SipSmartER, an Intervention to Reduce Sugar-sweetened Beverages
A NA study of Sugary Beverages, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 1,013
- Enrollment target
- 1
- Study location
NCT03740113: Completed NA study of Sugary Beverages, sponsored by University of Virginia.
NCT03740113 is a NA study of Sugary Beverages that has completed, run by University of Virginia. The registered enrollment target is 1,013 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03740113, a NA study of Sugary Beverages, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,013 participants
- Enrollment target
- 1
- Study location
Study Summary
Overall Goal: To determine the effectiveness of Kids SIPsmartER in improving sugar-sweetened beverages behaviors among 7th grade students. Secondary aims are to determine (1) changes in secondary student outcomes (e.g. quality of life, BMI z-score, theory-related variables, health and media literacy), (2) changes in caregiver SSB behaviors and home environment, (3) maintenance of outcomes at 19-months post-baseline, (4) assess the reach and representativeness of Kids SIPsmartER, among students and caregivers, and (5) implementation, adoption, and maintenance among teachers and schools.
Primary Outcome
Change in ounces of sugar sweetened beverage consumption from Baseline to 7-months as measured via the validated Beverage Intake Questionnaire (BEVQ-15). Participants were asked to report how often and how much of the following sugary drinks they consumed in the past 30 days: regular soft drinks, sweetened juice beverage/drink, sweetened tea, coffee with sugar, energy/sports drinks. Using standardized and validated scoring procedures, daily totals for each of the sugary beverages were determined
Conditions Studied
Interventions
- BEHAVIORAL Kids SipSmartER
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,013 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2024-06-07 |
| Phase | NA |
What the finished NCT03740113 record still lists
NCT03740113 is an interventional study that assigns participants to a tested intervention. Its 1,013 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 1 condition, with Sugary Beverages appearing as the primary indexed condition, and to 1 intervention - of which Kids SipSmartER is the first listed.
NCT03740113 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03740113 about?
NCT03740113 is a clinical study titled "Kids SipSmartER, an Intervention to Reduce Sugar-sweetened Beverages". Overall Goal: To determine the effectiveness of Kids SIPsmartER in improving sugar-sweetened beverages behaviors among 7th grade students. Secondary aims are to determine (1) changes in secondary student outcomes (e.g. quality of life, BMI z-score, theory-related variables, health and media literacy...
What is the current status of trial NCT03740113?
This trial is currently completed. It is a NA study. The enrollment target is 1,013 participants. The study started on 2018-08-15. Estimated completion is 2024-06-07.
What conditions does trial NCT03740113 study?
This clinical trial studies the following conditions: Sugary Beverages.
What interventions are being tested in trial NCT03740113?
The interventions under investigation include: Kids SipSmartER (BEHAVIORAL).
Who is sponsoring clinical trial NCT03740113?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03740113 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sugary Beverages
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03740113's enrollment target sits among peer trials
1,013 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI